The 11-wk chow reversal period resulted in near-complete regression of hepatic steatosis; however, lobular inflammation was increased over this same period resulting no change in the composite MASH activity score (albeit the CD45 proportional area decreased markedly, see further discussion below). This evidence concerns the gene PTPRC and fatty liver disease.